Similar articles for PMID: 8589035

Year	Number of Results
1994	5
1995	35
1996	28
1997	21
1998	8
1999	1
2000	1
2001	1
2002	1
2004	2
2005	1
2008	1
2009	1
2010	1
2013	1
2014	2
2019	1
2024	0

1

Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas.

Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA Jr, Goodfellow PJ. Bartsch D, et al. Genes Chromosomes Cancer. 1995 Nov;14(3):189-95. doi: 10.1002/gcc.2870140306. Genes Chromosomes Cancer. 1995. PMID: 8589035

2

Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.

Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA. Huang L, et al. Cancer Res. 1996 Mar 1;56(5):1137-41. Cancer Res. 1996. PMID: 8640773

3

Low frequency of CDKN2 mutation in endometrial carcinomas.

Peiffer SL, Bartsch D, Whelan AJ, Mutch DG, Herzog TJ, Goodfellow PJ. Peiffer SL, et al. Mol Carcinog. 1995 Aug;13(4):210-2. doi: 10.1002/mc.2940130403. Mol Carcinog. 1995. PMID: 7646759

4

Alterations of CDKN2 (p16) in non-small cell lung cancer.

de Vos S, Miller CW, Takeuchi S, Gombart AF, Cho SK, Koeffler HP. de Vos S, et al. Genes Chromosomes Cancer. 1995 Nov;14(3):164-70. doi: 10.1002/gcc.2870140303. Genes Chromosomes Cancer. 1995. PMID: 8589032

5

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.

Pollock PM, Pearson JV, Hayward NK. Pollock PM, et al. Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.

6

MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.

Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B. Moulton T, et al. Am J Pathol. 1995 Mar;146(3):613-9. Am J Pathol. 1995. PMID: 7887443 Free PMC article.

7

Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.

Zhou X, Suzuki H, Shimada Y, Imamura M, Yin J, Jiang HY, Tarmin L, Abraham JM, Meltzer SJ. Zhou X, et al. Genes Chromosomes Cancer. 1995 Aug;13(4):285-90. doi: 10.1002/gcc.2870130409. Genes Chromosomes Cancer. 1995. PMID: 7547637

8

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.

Schuyer M, van Staveren IL, Klijn JG, vd Burg ME, Stoter G, Henzen-Logmans SC, Foekens JA, Berns EM. Schuyer M, et al. Br J Cancer. 1996 Oct;74(7):1069-73. doi: 10.1038/bjc.1996.491. Br J Cancer. 1996. PMID: 8855976 Free PMC article.

9

Infrequent CDKN2 mutation in human differentiated thyroid cancers.

Tung WS, Shevlin DW, Bartsch D, Norton JA, Wells SA Jr, Goodfellow PJ. Tung WS, et al. Mol Carcinog. 1996 Jan;15(1):5-10. doi: 10.1002/(SICI)1098-2744(199601)15:1<5::AID-MC2>3.0.CO;2-K. Mol Carcinog. 1996. PMID: 8561866

10

Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.

Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K. Yoshida S, et al. Cancer Res. 1995 Jul 1;55(13):2756-60. Cancer Res. 1995. PMID: 7796400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year